SEC Company Response from Sonoma Pharmaceuticals, Inc. (SNOA) (CIK 0001367083) (SNOA) — Nov 16, 2018

Sonoma Pharmaceuticals, Inc. (SNOA) (CIK 0001367083)
Date: Nov. 16, 2018 · CIK: 0001367083 · Accession: 0001683168-18-003470

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-227806

Date

November 16, 2018

Author

Jim Schutz

Form

CORRESP

Company

Sonoma Pharmaceuticals, Inc. (SNOA) (CIK 0001367083)

Letter

VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance File No. 333-227806 Acceleration Request Requested Date: November 16, 2018 Requested Time: 4:30 P.M. Eastern Standard Time

Re: Sonoma Pharmaceuticals, Inc.

Dear Ms. Yale:

Pursuant to Rule 461 of the Rules and Regulations promulgated under the Securities Act of 1933, as amended, Sonoma Pharmaceuticals, Inc. (the “Company”), hereby requests that the above-captioned Registration Statement on Form S-1, as amended, (the “Registration Statement”) be accelerated to November 16, 2018 at 4:30 pm EST or as soon as practicable thereafter.

The cooperation of the staff in meeting the Company’s request is very much appreciated. Please call Amy Trombly at (617) 243-0060 if you have any questions or if we can otherwise be of assistance to you.

Very truly yours,
Sonoma Pharmaceuticals, Inc.

Show Raw Text

CORRESP
1
filename1.htm

November 16, 2018

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E., Mail Stop 3030

Washington, DC 20549

    Attn:
     Dorrie Yale

    Re:
    Sonoma Pharmaceuticals, Inc.

Registration Statement on Form S-1

Filed October 12, 2018, as amended

File No. 333-227806

    Acceleration Request

    Requested Date: November 16, 2018

Requested Time: 4:30
P.M. Eastern Standard Time

Dear Ms. Yale:

Pursuant to Rule 461 of the Rules and Regulations
promulgated under the Securities Act of 1933, as amended, Sonoma Pharmaceuticals, Inc. (the “Company”), hereby requests
that the above-captioned Registration Statement on Form S-1, as amended, (the “Registration Statement”) be accelerated
to November 16, 2018 at 4:30 pm EST or as soon as practicable thereafter.

The cooperation of the staff in meeting
the Company’s request is very much appreciated. Please call Amy Trombly at (617) 243-0060 if you have any questions or if
we can otherwise be of assistance to you.

    Very truly yours,

Sonoma Pharmaceuticals, Inc.

/s/ Jim Schutz

By: Jim Schutz

       Chief Executive Officer

cc: Amy Trombly, Esq.

SecProbe.io